Literature DB >> 25738002

Oxcarbazepine induced maculopapular rash - a case report.

Arunava Biswas1, Ritabrata Mitra2, Sukanta Sen1, Agnik Pal3, Santanu Kumar Tripathi4.   

Abstract

Unlike carbamazepine, newer anti epileptic drug like oxcarbazepine, reports fewer side effects. In this report we describe a case of oxcarbazepine induced maculopapular rash probably happened because of a drug interaction with isoniazid, and a brief review of the existing literature is presented herewith. A 40-year-old male patient received oxcarbazepine 300mg twice daily along with other anti-tubercular drugs including isoniazid (300mg) once daily since two days. Extensive cutaneous rash with intense itching developed which subsided on discontinuation of oxcarbazepine. This case highlights the fact that there is a potential possibility of drug-drug interaction between oxcarbazepine and isoniazid and concomitant use of these two drugs should better be avoided during clinical practice.

Entities:  

Keywords:  Isoniazid; Maculopapular rash; Oxcarbazepine

Year:  2015        PMID: 25738002      PMCID: PMC4347093          DOI: 10.7860/JCDR/2015/10744.5375

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  9 in total

1.  Preventability and severity assessment in reporting adverse drug reactions.

Authors:  S C Hartwig; J Siegel; P J Schneider
Journal:  Am J Hosp Pharm       Date:  1992-09

2.  Cutaneous reactions induced by oxcarbazepine in Southern Han Chinese: incidence, features, risk factors and relation to HLA-B alleles.

Authors:  Na He; Fu-Li Min; Yi-Wu Shi; Jing Guo; Xiao-Rong Liu; Bing-Mei Li; Jin-Hua Zhou; Yang-Mei Ou; Jian-Xiang Liao; Wei-Ping Liao
Journal:  Seizure       Date:  2012-07-20       Impact factor: 3.184

Review 3.  Pharmacokinetic interactions of the new antiepileptic drugs.

Authors:  B Rambeck; U Specht; P Wolf
Journal:  Clin Pharmacokinet       Date:  1996-10       Impact factor: 6.447

4.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

5.  Pilot association study of oxcarbazepine-induced mild cutaneous adverse reactions with HLA-B*1502 allele in Chinese Han population.

Authors:  Fa-yun Hu; Xin-tong Wu; Dong-mei An; Bo Yan; Hermann Stefan; Dong Zhou
Journal:  Seizure       Date:  2010-12-18       Impact factor: 3.184

6.  Antiepileptic drug-induced skin reactions: a retrospective study and analysis in 3793 Chinese patients with epilepsy.

Authors:  Xiang-qing Wang; Sen-yang Lang; Xiao-bing Shi; Hui-jun Tian; Rong-fei Wang; Fei Yang
Journal:  Clin Neurol Neurosurg       Date:  2012-02-07       Impact factor: 1.876

7.  Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians.

Authors:  Timir Y Mehta; Laxman M Prajapati; Bharti Mittal; Chaitanya G Joshi; Jayesh J Sheth; Dinesh B Patel; Dinkar M Dave; Ramesh K Goyal
Journal:  Indian J Dermatol Venereol Leprol       Date:  2009 Nov-Dec       Impact factor: 2.545

8.  Genetic predisposition to oxcarbazepine induced Stevens-Johnson syndrome.

Authors:  Pranay Wal; Ankita Wal; Umeshwar Pandey; Awani K Rai; Anil Bhandari
Journal:  Indian J Crit Care Med       Date:  2011-07

9.  Oxcarbazepine-induced Stevens Johnson syndrome: A rare case report.

Authors:  S R Sharma; Nalini Sharma; M E Yeolekar
Journal:  Indian Dermatol Online J       Date:  2011-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.